MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.

Saved in:
Bibliographic Details
Title: MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
Authors: Ching TH; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; Department of Psychological Sciences, University of Connecticut, Mansfield, CT, USA., Williams MT; School of Psychology, University of Ottawa, Ottawa, ON, Canada., Wang JB; MAPS Public Benefit Corporation, Santa Cruz, CA, USA., Jerome L; MAPS Public Benefit Corporation, Santa Cruz, CA, USA., Yazar-Klosinski B; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA., Emerson A; MAPS Public Benefit Corporation, Santa Cruz, CA, USA., Doblin R; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA.
Source: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2022 Aug; Vol. 36 (8), pp. 974-986. Date of Electronic Publication: 2022 Jun 21.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35727042
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ching+TH%22">Ching TH</searchLink>; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; Department of Psychological Sciences, University of Connecticut, Mansfield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Williams+MT%22">Williams MT</searchLink>; School of Psychology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Wang+JB%22">Wang JB</searchLink>; MAPS Public Benefit Corporation, Santa Cruz, CA, USA.<br /><searchLink fieldCode="AU" term="%22Jerome+L%22">Jerome L</searchLink>; MAPS Public Benefit Corporation, Santa Cruz, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yazar-Klosinski+B%22">Yazar-Klosinski B</searchLink>; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA.<br /><searchLink fieldCode="AU" term="%22Emerson+A%22">Emerson A</searchLink>; MAPS Public Benefit Corporation, Santa Cruz, CA, USA.<br /><searchLink fieldCode="AU" term="%22Doblin+R%22">Doblin R</searchLink>; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228907828%22">Journal of psychopharmacology (Oxford, England)</searchLink> [J Psychopharmacol] 2022 Aug; Vol. 36 (8), pp. 974-986. <i>Date of Electronic Publication: </i>2022 Jun 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8907828 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1461-7285 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202698811%22">02698811 </searchLink><i>NLM ISO Abbreviation: </i>J Psychopharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35727042
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/02698811221104052
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 974
    Titles:
      – TitleFull: MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ching TH
      – PersonEntity:
          Name:
            NameFull: Williams MT
      – PersonEntity:
          Name:
            NameFull: Wang JB
      – PersonEntity:
          Name:
            NameFull: Jerome L
      – PersonEntity:
          Name:
            NameFull: Yazar-Klosinski B
      – PersonEntity:
          Name:
            NameFull: Emerson A
      – PersonEntity:
          Name:
            NameFull: Doblin R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1461-7285
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Journal of psychopharmacology (Oxford, England)
              Type: main
ResultId 1